The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.
about
Executive dysfunction in Parkinson's disease and timing deficitsα-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson diseaseNeuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stressThe Genetic Basis of Cognitive Impairment and Dementia in Parkinson's DiseaseMild cognitive impairment in Parkinson's diseaseMild cognitive impairment in Parkinson's disease.Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor SymptomsCognitive function in early Parkinson's disease: a population-based studyPrecompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson's DiseaseParkinson's Disease and Cognitive ImpairmentParkinson Disease and Dementia.A randomized controlled trial of an enhanced interdisciplinary community based group program for people with Parkinson's disease: study rationale and protocol.Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognitionRestriction of dopamine signaling to the dorsolateral striatum is sufficient for many cognitive behaviors.Impaired verbal memory in Parkinson disease: relationship to prefrontal dysfunction and somatosensory discriminationThe spectrum of cognitive disorders in Parkinson's disease: a data-driven approach.Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline data.Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson diseaseGlycoproteomics in neurodegenerative diseases.Prospective memory in Parkinson disease across laboratory and self-reported everyday performance.Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.Salience and Default Mode Network Coupling Predicts Cognition in Aging and Parkinson's Disease.Biomarkers for cognitive impairment in Parkinson disease.The spectrum of cognitive impairment in Lewy body diseasesExecutive functioning in daily life in Parkinson's disease: initiative, planning and multi-task performanceGenetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD studyDefining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.Association between cognition and function in patients with Parkinson disease with and without dementia.Premotor and nonmotor features of Parkinson's disease.Saccadic latency in hepatic encephalopathy: a pilot study.Cognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models?Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson's disease.Psychiatric aspects of Parkinson's disease.Virtual multiple errands test (VMET): a virtual reality-based tool to detect early executive functions deficit in Parkinson's diseaseA differential deficit in time- versus event-based prospective memory in Parkinson's disease.The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients.Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.Cognitive rehabilitation for executive dysfunction in Parkinson's disease: application and current directions.
P2860
Q21090466-63F5E3F1-EF35-4F6E-840B-56A72DBC5BF4Q21090919-8371E310-00AC-4C34-895F-6C0F2C8B624FQ24678238-9D32F7AF-830B-43DE-AC50-7ED58CC142D1Q26744716-963EF5E5-B56D-409C-85A2-6FA35F984BB5Q27007766-760B735F-42A8-4BBB-A6A5-F865DB7CDA07Q27021220-0D3A6FD8-D9FF-46E5-9F69-7CD34F736619Q28075345-5155C88D-96F2-4FEC-8E19-63C015E92ED8Q28249085-7284FA5A-70B5-44CD-845C-2203373DFD18Q28601965-2D57173E-6642-4A74-BFEC-C3C7DC955B0CQ30239814-A937FD41-9057-4DD9-8E3E-35FB55B74770Q30248574-466259BA-0E47-45A4-A34F-BF33BD07C477Q30467565-6B58ACEB-F4A5-41DE-B103-2B1FF678C8F0Q30482965-B944C0DA-B64E-4DA8-A144-4575457D4085Q30489765-6C40D189-EB52-4AE7-B729-C007098A02E1Q30492753-2915AA82-1966-42E5-B58F-6F1C504DBA01Q30593620-BB94B32D-4AB0-49E7-BBBE-4A8A08E51A94Q30611520-9844EE0C-C5C0-4690-8252-153B0148F39EQ31096478-6F29C3A6-15F0-478D-93B5-2B53416BF2F1Q33516505-D7151348-6EE1-417E-BAF6-2974ADF9743CQ33563387-403B5D6D-4CBA-4044-BEFD-914166C9B687Q33731116-50EC0402-4D12-4635-A45B-A0B082FBA6A9Q33754677-777CAF13-460C-4111-83CE-66BB57A18EDDQ33787942-28CF03C6-DDF5-447C-871C-75D66051CFC5Q33896664-AE904BFE-7CE4-490C-8F9A-E99C1592D131Q34019751-36899B75-671C-4FF7-8EAB-CEA3624C015CQ34113707-28A1BCC0-6CD3-4DC0-BF59-2469426F4AEBQ34174901-66A625F3-8814-4FC8-BD20-9CDC8AFE4528Q34183061-291D3593-0FD9-42A3-BC13-90501B4460CBQ34235570-06F16AEE-25A8-49FC-A3DA-0AC2E0709514Q34274224-B720A74F-0DA0-4865-B73E-A3BDBA0513C3Q34274378-C573A04C-2241-4748-AFEF-8AC67B5535A3Q34307633-A31B1045-3E61-43FA-8BB3-5025D63478CFQ34399250-BFDC55AA-5E9A-4263-8401-4BD8AF43ED42Q34574771-672B12B7-4DA5-43E3-81ED-06AF17B82995Q34637988-F62291BD-9B87-4431-ABED-0A4081025238Q34680865-D3AA06AF-9A7B-405A-9124-B217C31737A0Q34925276-B5EC2990-5BB0-4CF5-B4F2-11885BD46D98Q35158915-1693EBDF-D042-480A-8178-777BD5A9402EQ35234522-737DFF30-E337-40A6-AF54-65C9FE8E4D86Q35550727-FCCA8C9A-84E1-45AC-B14D-08FBA8AE8134
P2860
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The cognitive ability of an in ...... in the UK. The CamPaIGN study.
@en
The cognitive ability of an in ...... in the UK. The CamPaIGN study.
@nl
type
label
The cognitive ability of an in ...... in the UK. The CamPaIGN study.
@en
The cognitive ability of an in ...... in the UK. The CamPaIGN study.
@nl
prefLabel
The cognitive ability of an in ...... in the UK. The CamPaIGN study.
@en
The cognitive ability of an in ...... in the UK. The CamPaIGN study.
@nl
P50
P356
P1433
P1476
The cognitive ability of an in ...... in the UK. The CamPaIGN study.
@en
P2093
Carol E G Brayne
P304
P356
10.1093/BRAIN/AWH067
P407
P577
2003-12-22T00:00:00Z